Company
Distalmotion
Distalmotion is a Swiss surgical robotics company based in Lausanne, developing the Dexter robotic surgery system for minimally invasive abdominal surgery,…
- Founded
- 2012
- HQ
- Lausanne, Switzerland
- Status
- private (raised $150M Nov 2025)
- Models
- 1
Verified profile
4
Sources on record
1
Tracked changes
Updated 1 month ago
Last verified change
Overview
Distalmotion is a Swiss surgical robotics company based in Lausanne, developing the Dexter robotic surgery system for minimally invasive abdominal surgery, combining remote-center motion with a compact, ergonomic surgical platform.
Verified record
- Verified deployments
- None on file
- Active incidents
- 1 incident on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Models (1)
View all models →Current leadership (2)
- Greg Roche CEOIR-verified
- Lionel Flaction Co-founder & CTOIR-verified
Founders (2)
- Lionel Flactioncofounderfounded 2012-01-01
- Ricardo Beiracofounderfounded 2012-01-01no longer at company
Board (2)
- Chas McKhann chair
- Greg Roche director
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Incidents affecting Distalmotion (1)
- Distalmotion Dexter robot receives FDA 510(k) clearance for gynecology indications2026-06-15 · Regulatory action
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Recent coverage
Distalmotion in third-party press
Peer companies
- Intuitive Surgical2 models
- Johnson & Johnson2 models
- Stryker2 models
- Vantis2 models
- Asensus Surgical1 model
- Auris Health1 model
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- growth
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Sources (4)
Common questions
- What is Distalmotion?
- Distalmotion is a Swiss surgical robotics company based in Lausanne, developing the Dexter robotic surgery system for minimally invasive abdominal surgery, combining remote-center motion with a compact, ergonomic surgical platform.
- Where is Distalmotion based?
- Distalmotion is based in Lausanne, Switzerland.
- When was Distalmotion founded?
- Distalmotion was founded in 2012.
- What does Distalmotion make?
- Distalmotion has 1 robot model on the DEPLOY registry: Dexter (Distalmotion builds both physical robots and the AI that runs them).
- Where does Distalmotion operate robots?
- Distalmotion is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Are there any incidents involving Distalmotion?
- 1 active incident involving Distalmotion is on the DEPLOY registry. Each is a sourced, append-only record; retracted incidents are suppressed from this view.
- Is Distalmotion safe?
- Distalmotion has 1 active incident on record in the DEPLOY registry. 1 incident on record (1 minor). Most recent: Jun 2026. Retracted incidents are excluded from this count.
Methodology: Verified · 4 sources (1 primary) · last reviewed 2026-07-03
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-07-03
Sources by quality tier
- 3
- unclassified
- Unclassified source
- 1
- primary-company-ir
- Company IR disclosure
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Distalmotion.Peer companies
- Intuitive Surgical2 models
- Johnson & Johnson2 models
- Stryker2 models
- Vantis2 models
- Asensus Surgical1 model
- Auris Health1 model
In the press
Recent coverage mentioning Distalmotion from third-party publications. Automatically surfaced; not part of the verified registry record.
Distalmotion receives FDA 510k clearance for additional gynecology indications for DEXTER
Distalmotion received FDA 510k clearance for sacrocolpopexy, sacrocervicopexy, sacrohysteropexy, and endometriosis resection for DEXTER, its fourth US clearance adding to…
Distalmotion Dexter robot cleared for gynecology indications by FDA
Distalmotion Dexter robotic surgery system cleared for sacrocolpopexy, sacrocervicopexy, sacrohysteropexy. Targeting ASC robotic gynecology programs.
5 robotic surgery trends to watch in 2026
MedTech Dive: Soft tissue robotic systems expanding into new specialties. Medtronic Hugo competition with Intuitive. Distalmotion Dexter gaining traction. ASC adoption growing.
Machine-readable surfaces
- Markdown mirror: /companies/distalmotion.md
- RSS feed: /companies/distalmotion/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/bba39508-3e95-4e2f-b736-9bd5ff7e567b
- Revision history: /companies/distalmotion/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Intuitive Surgical2 models
- Johnson & Johnson2 models
- Stryker2 models
- Vantis2 models
- Asensus Surgical1 model
- Auris Health1 model
DEPLOY Intelligence Score
23.9/ 100
6-month trend
Analysis
Clean safety record across 1 verified deployment. Limited public visibility and press coverage relative to peers.
Signal flags
Dimension breakdown
Safety Record
Funding Health
Deployment Scale
IP Activity
Hiring Signal
Market Presence
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
Last computed: Jul 3, 2026
Intelligence layer